Skip to main content
Displaying 161 of 2889 articles.

New method gives scientists a better look at how HIV infects and takes over its host cells

Viruses attack cells and commandeer their machinery in a complex and carefully orchestrated invasion. Scientists have long probed this process for insights into biology and disease, but essential details still remain out of reach. A new approach, developed by a team of researchers led by The Rock...

35 labs and counting: How the Robertson Therapeutic Development Fund speeds translational research at Rockefeller

by Alexandra MacWade, assistant editor Developing a new medical product is a complex, high-risk endeavor. Of the thousands of clinically promising concepts scientists formulate each year, only a small fraction move beyond the lab. The Robertson TDF was created to advance work that has gone beyon...

Antibody therapy opens door to potential new treatment for HIV

The development of antiretroviral therapy, a combination of drugs that slows the replication of HIV in the body, has transformed the treatment of this infection. What was once a certain death sentence is now a chronic condition that people can live with for decades. But this therapy has drawbacks...

Charles Rice wins Belgium’s highest scientific prize

Charles M. Rice, Maurice R. and Corinne P. Greenberg Professor in Virology and head of the Laboratory of Virology and Infectious Disease, has been honored with the 2016 InBev-Baillet Latour Health Prize for his work on the hepatitis C virus. Queen Mathilde of Belgium presented Rice with the prize...

An experimental Alzheimer’s drug reverses genetic changes thought to spur the disease

Aging takes its toll on the brain, and the cells of the hippocampus—a brain region with circuitry crucial to learning and memory—are particularly vulnerable to changes that can lead to Alzheimer’s disease or cognitive decline. With the hope of counteracting the changes that can lead to these t...

Drug discovery institute seeks proposals for innovative antibody projects

by Julie Grisham, freelance writer The Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI) has reached a new milestone in its effort to advance the development of new drugs based on basic science discoveries made at Rockefeller and its two neighboring institutions, Weill Cornell M...

In the News - New York Times - Vosshall

Mapping a Genetic Strategy to Fight the Zika Virus "Aware of the new technology, Dr. Vosshall floated the idea of a new Aedes map on Twitter: 'The Aedes aegypti mosquito is infecting millions with #Zika and #Dengue,' she wrote on Jan. 28, 'but we still haven’t put all the pieces of its genome tog...

Parasites reveal how evolution has molded an ancient nuclear structure

Long before animals evolved from sponges, and before plants evolved out of algae, there was a pivotal event that allowed complex, multicellular organisms to arise: the development of the nucleus in single-celled organisms. Eukaryotes, one of the three main branches of living organisms, are define...

Awards, arrivals, and promotions

Congratulations to our latest award winners: Cori Bargmann has won the 2016 Edward M. Scolnick Prize in Neuroscience, an award given by the McGovern Institute for Brain Research at MIT to recognize outstanding advances in the field. She is being honored for her work on the genetic and neural mech...

A virus common among livestock depends on a microRNA to replicate

In the ongoing arms race between pathogenic viruses and the cells they infect, each side needs every advantage it can get. One way wily viruses can get a leg up is by subverting the microRNAs (miRNAs) of their host. These miRNAs are small stretches of RNA made by host cells to regulate gene expre...